Evidence map›Paper›PMID 41476193›Full record

ArticleScientific reports2025

Curvelet-enhanced transformer architecture for blurred action fine-grained detection.

Yuxiang Ren, Zhetao Guo, Wei Zhang, Yushi Shen, Ying Xing

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Clinicopathological predictors of central lymph node metastasis in clinically node-negative papillary thyroid carcinoma: a retrospective cohort analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuxiang RenBeijing Dianjing Ciyuan Network Technology Co.,Ltd, Beijing, 100124, China.
Zhetao GuoCloudspace Technology Co., Ltd, Beijing, 100176, China. gzt@ieee.org.
Wei ZhangThe Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, 100029, China.
Yushi ShenNovNet Computing System Tech Company, Beijing, 100081, China.
Ying XingSchool of Intelligent Engineering and Automation, Beijing University of Posts and Telecommunications, Beijing, 100876, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study proposes a novel Multi Curvelet Transformer Network (MCTN) for fine-grained human behavior recognition in dynamic video scenarios. A key challenge in this field lies in accurately identifying human actions under adverse conditions such as motion blur, occlusion, and varying illumination. To address this, we introduce a motion blur restoration module leveraging the curvelet transform to enhance motion image clarity, thereby improving downstream behavior detection. Furthermore, we enhance the Transformer architecture by embedding curvelet-based multi-scale attention mechanisms, which significantly improve the model's ability to extract spatial-temporal features at different resolutions. The proposed network also adopts a multi-curvelet transform structure to deepen semantic representation. Experimental results on benchmark datasets, including an action recognition dataset and the MSCOCO dataset, demonstrate that MCTN achieves superior performance, reaching a mean average precision (mAP) of 0.822. These results underscore the potential of MCTN in real-time intelligent video analysis and human-computer interaction applications.

Indexed as

Human behavior recognitionMotion blur restorationMulti curveletTransformer

Identifiers

PMID41476193
PMCPMC12852775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.